Page last updated: 2024-08-24

3-iodobenzylguanidine and bevantolol

3-iodobenzylguanidine has been researched along with bevantolol in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hamada, M; Hara, Y; Matsunaka, T; Nakata, S; Ogimoto, A; Ohtsuka, T; Saeki, H; Shigematsu, Y; Suzuki, J	1

Trials

1 trial(s) available for 3-iodobenzylguanidine and bevantolol

Article	Year
Use of thallium-201 myocardial scintigraphy for the prediction of the response to beta-blocker therapy in patients with dilated cardiomyopathy. Circulation journal : official journal of the Japanese Circulation Society, 2002, Volume: 66, Issue:12 Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Adult; Aged; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Female; Forecasting; Heart; Hemodynamics; Humans; Male; Metoprolol; Middle Aged; Multivariate Analysis; Probability; Propanolamines; Radionuclide Imaging; Radiopharmaceuticals; Thallium Radioisotopes; Treatment Outcome	2002

Article

Year

Use of thallium-201 myocardial scintigraphy for the prediction of the response to beta-blocker therapy in patients with dilated cardiomyopathy.

Circulation journal : official journal of the Japanese Circulation Society, 2002, Volume: 66, Issue:12

Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Adult; Aged; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Female; Forecasting; Heart; Hemodynamics; Humans; Male; Metoprolol; Middle Aged; Multivariate Analysis; Probability; Propanolamines; Radionuclide Imaging; Radiopharmaceuticals; Thallium Radioisotopes; Treatment Outcome

2002